"Non small lung cancer" trang 1 - tải miễn phí từ tailieunhanh
The clinical significance of Psoriasin for non-small cell lung cancer patients and its biological impact on lung cancer cell functions

The clinical significance of Psoriasin for non-small cell lung cancer patients and its biological impact on lung cancer cell functions
10    83    1
Assessment of the psychosocial and economic impact according to sex in non-small cell lung cancer patients: An exploratory longitudinal study

Assessment of the psychosocial and economic impact according to sex in non-small cell lung cancer patients: An exploratory longitudinal study
9    59    3
TIPE3 differentially modulates proliferation and migration of human non-small-cell lung cancer cells via distinct subcellular location

TIPE3 differentially modulates proliferation and migration of human non-small-cell lung cancer cells via distinct subcellular location
10    57    1
Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: Associations with environmental factors and clinical outcomes

Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: Associations with environmental factors and clinical outcomes
9    1    1
Expression of Ciz1b in patients with non small cell lung cancer

Expression of Ciz1b in patients with non small cell lung cancer
7    102    0
Impact of fibrinogen levels and modified Glasgow prognostic score on survival of stage III/N2 non-small cell lung cancer patients treated with neoadjuvant therapy and radical resection

Impact of fibrinogen levels and modified Glasgow prognostic score on survival of stage III/N2 non-small cell lung cancer patients treated with neoadjuvant therapy and radical resection
8    1    1
The result of adjuvant vinorelbine plus cisplatin in completely resected stage IB-IIIA non-small cell lung cancer at Hanoi Medical University Hospital

The result of adjuvant vinorelbine plus cisplatin in completely resected stage IB-IIIA non-small cell lung cancer at Hanoi Medical University Hospital
6    46    1
Results of concurrent chemoradiotherapy of 30 patients with inoperable stage III non-small cell lung cancer, used PET/CT planning radiation plan at 108 Military Central Hospital

Results of concurrent chemoradiotherapy of 30 patients with inoperable stage III non-small cell lung cancer, used PET/CT planning radiation plan at 108 Military Central Hospital
12    26    1
Expression of long non-coding RNAs (lncRNAs) has been dysregulated in non-small cell lung cancer tissues

Expression of long non-coding RNAs (lncRNAs) has been dysregulated in non-small cell lung cancer tissues
17    77    1
Blood test shows high accuracy in detecting stage I non-small cell lung cancer

Blood test shows high accuracy in detecting stage I non-small cell lung cancer
11    107    0
NKX2–1 expression as a prognostic marker in early-stage non-small-cell lung cancer

NKX2–1 expression as a prognostic marker in early-stage non-small-cell lung cancer
9    47    1
In vitro and in vivo effects of geranylgeranyltransferase I inhibitor P61A6 on non-small cell lung cancer cells

In vitro and in vivo effects of geranylgeranyltransferase I inhibitor P61A6 on non-small cell lung cancer cells
10    57    1
Prognostic value of patient-reported outcome measures (PROMs) in adults with non-small cell Lung Cancer: A scoping review

Prognostic value of patient-reported outcome measures (PROMs) in adults with non-small cell Lung Cancer: A scoping review
10    1    1
Value of PET/CT in diagnosis of lung cancer

Value of PET/CT in diagnosis of lung cancer
7    123    0
Randomized, open-label phase II study of brigatinib and carboplatin plus pemetrexed and brigatinib alone for chemotherapy-naive patients with ALK-rearranged non-squamous non-small cell lung cancer: Treatment rationale and protocol design of the B-DASH study (WJOG 14720 L)

Randomized, open-label phase II study of brigatinib and carboplatin plus pemetrexed and brigatinib alone for chemotherapy-naive patients with ALK-rearranged non-squamous non-small cell lung cancer: Treatment rationale and protocol design of the B-DASH study (WJOG 14720 L)
6    1    1
HOXA9 gene promotor methylation and copy number variation of SOX2 and HV2 genes in cell free DNA: A potential diagnostic panel for non‑small cell lung cancer

HOXA9 gene promotor methylation and copy number variation of SOX2 and HV2 genes in cell free DNA: A potential diagnostic panel for non‑small cell lung cancer
9    2    1
LncRNA MAGI2-AS3 is downregulated in non-small cell lung cancer and may be a sponge of miR-25

LncRNA MAGI2-AS3 is downregulated in non-small cell lung cancer and may be a sponge of miR-25
7    33    1
Evaluation of the operation outcomes of non small cell lung cancer stage I - IIIA in Hanoi Medical University Hospital

Evaluation of the operation outcomes of non small cell lung cancer stage I - IIIA in Hanoi Medical University Hospital
4    88    0
Discovery and anti-cancer evaluation of two novel non-ATP-competitive FGFR1 inhibitors in non-small-cell lung cancer

Discovery and anti-cancer evaluation of two novel non-ATP-competitive FGFR1 inhibitors in non-small-cell lung cancer
9    48    1
The landscape of immune checkpoint inhibitor therapy in advanced lung cancer

The landscape of immune checkpoint inhibitor therapy in advanced lung cancer
18    74    1